检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
出 处:《临床医学进展》2024年第5期1046-1054,共9页Advances in Clinical Medicine
摘 要:卒中是全球第二大死亡原因,在我国也是导致成人残疾、死亡的首要疾病,其中最常见的卒中类型是急性缺血性脑卒中。缺血性脑卒中(Ischemic stroke, IS)是由血管内血栓形成或栓塞引起脑血流中断,使脑血流灌注下降,主要是以突然起病、局灶性神经功能缺损为特点的急性脑血管疾病。越来越多的研究表明,代谢紊乱与IS的发生、发展密切相关。有研究结果表明,兴奋性氨基酸代谢途径异常与IS的发生、发展密切相关。本综述探讨了兴奋性氨基酸在IS中的进展,强调了其在缺血性卒中的病理生理机制及目前作为潜在治疗靶点的可能性,并为进一步研究提供参考,对兴奋性氨基酸与缺血性脑卒中进行综述。Stroke is the second leading cause of death worldwide and the leading cause of disability and death in adults in China, with the most common type of stroke being acute ischemic stroke. Ischemic stroke (IS) is an acute cerebrovascular disease characterized mainly by sudden onset and focal neurological deficits due to interruption of cerebral blood flow caused by intravascular thrombosis or embolism, resulting in decreased cerebral perfusion. More and more studies have shown that metabolic disorders are closely related to the onset and progress of IS. Studies have shown that the abnormal excitatory amino acid metabolic pathway is closely related to the occurrence and development of IS. In this review, we discuss the progress of excitatory amino acids in IS, highlight the pathophysiological mechanism of excitatory amino acids in ischemic stroke and the possibility of their being potential therapeutic targets at present, and provide reference for further research.
分 类 号:R74[医药卫生—神经病学与精神病学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.170